Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients — The IMPROVED multi-centre study

[1]  P. Schnabel,et al.  Allograft rejection of ISHLT grade >/=3A occurring late after heart transplantation--a distinct entity? , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  P. Macdonald,et al.  Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  L. Sharples,et al.  The incidence of end-stage renal failure in 17 years of heart transplantation: a single center experience. , 2002, The Journal of Heart and Lung Transplantation.

[4]  J. Hosenpud,et al.  MYCOPHENOLATE MOFETIL VERSUS AZATHIOPRINE IN PATIENTS SURVIVING THE INITIAL CARDIAC TRANSPLANT HOSPITALIZATION: AN ANALYSIS OF THE JOINT UNOS/ISHLT THORACIC REGISTRY , 2001, Transplantation.

[5]  J. Fink,et al.  Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy. , 2001, Kidney international.

[6]  M. Manns,et al.  Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study , 2001, The Lancet.

[7]  B. Meiser,et al.  THE CLINICAL IMPACT OF CYCLOSPORINE NEPHROTOXICITY IN HEART TRANSPLANTATION , 2000, Transplantation.

[8]  B. Schorn,et al.  Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine. , 2000, Transplantation.

[9]  J. Obadia,et al.  Introduction of mycophenolate mofetil and cyclosporine withdrawal in heart transplant patients with progressive deteriorating renal function. , 2000, Transplantation proceedings.

[10]  D. Renlund,et al.  Three-Year Allograft Vasculopathy Results of the Multicenter Heart Transplant Mycophenolate Mofetil Randomized Trial , 1999 .

[11]  J. Squifflet,et al.  A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. , 1998, Transplantation.

[12]  J. Best,et al.  Risks and costs of end-stage renal disease after heart transplantation. , 1998, Transplantation.

[13]  D. Renlund,et al.  A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. , 1998, Transplantation.

[14]  A. Mimran,et al.  Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy. , 1998, Transplantation.

[15]  H. Sollinger,et al.  Preliminary Risk-Benefit Assessment of Mycophenolate Mofetil in Transplant Rejection , 1997, Drug safety.

[16]  S Greenland,et al.  A critical look at methods for handling missing covariates in epidemiologic regression analyses. , 1995, American journal of epidemiology.

[17]  G. Appel,et al.  Progressive renal insufficiency following cardiac transplantation: cyclosporine, lipids, and hypertension. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  R. Little.  Regression with Missing X's: A Review , 2011 .

[19]  M. Hammond,et al.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. , 1990, The Journal of heart transplantation.

[20]  A. Fabris,et al.  Progression of renal failure in patients with renal disease of diverse etiology on protein-restricted diet. , 1985, Kidney international.

[21]  S. Adler,et al.  Autosomal dominant polycystic kidney disease: presentation, complications, and prognosis. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  W. Mitch,et al.  A SIMPLE METHOD OF ESTIMATING PROGRESSION OF CHRONIC RENAL FAILURE , 1976, The Lancet.

[23]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .